#chemotherapy — Wednesday, August 12, 2026 (1 items)
| 1 | 💬 0 |
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.
(nature.com)
|
Nature Medicine 2026-08-12 | #clinical trial #immunotherapy #breast cancer #chemotherapy |